Advisory Committee Endorses Moderna's mRNA Flu Vaccine for Seniors

AI-generated NewsSnap summary based on source reporting.
Published: 2026-06-19
Category: health
Source: Los Angeles Times / Pharmacy Times
Original source

An independent FDA advisory panel has unanimously recommended Moderna's mFlusiva mRNA flu vaccine for adults aged 50 and above. This vaccine, utilizing similar technology to COVID-19 shots, showed a 27% greater reduction in flu cases during a large study. The FDA is expected to issue its final decision on approval by early August.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai